Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Item
http://www.wikidata.org/entity/Q28283647
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes.A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.Progress in the development of immunotherapy for the treatment of patients with cancer.Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinomaCancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implicationsDabrafenib in metastatic melanoma: a monocentric 'real life' experience.PRAME expression in hairy cell leukemia.PRAME expression and clinical outcome of breast cancerUpdate on vaccine development for renal cell cancer.Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Limited expression of cancer-testis antigens in renal cell carcinoma patients.Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies.
P2860

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Item
http://www.wikidata.org/entity/Q28283647
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@ast
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@en
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@nl
type
label
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@ast
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@en
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@nl
prefLabel
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@ast
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@en
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Heterogeneous expression of th ...... T-cell-based immunotherapies?
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921